Ardelyx, Inc. (ARDX)
6.35
+0.08
(+1.28%)
USD |
NASDAQ |
May 21, 16:00
6.345
0.00 (0.00%)
After-Hours: 19:59
Ardelyx Research and Development Expense (TTM) : 73.40M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.514B |
| PTC Therapeutics, Inc. | 447.15M |
| Syndax Pharmaceuticals, Inc. | 255.98M |
| Akebia Therapeutics, Inc. | 66.13M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |